Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2020 (Aricept) Extension in Dementia with Lewy Bodies
NCT00598650Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of donepezil in dementia with Lewy bodies (DLB), sponsored by Eisai Co., Ltd.. Started Feb 2008; status: completed.
02
Drugs
donepezil
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT00598650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598650.